AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Short Interest Update

AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) saw a significant decrease in short interest in the month of June. As of June 15th, there was short interest totaling 61,905 shares, a decrease of 42.5% from the May 31st total of 107,659 shares. Currently, 3.8% of the company’s shares are short sold. Based on an average trading volume of 32,605 shares, the short-interest ratio is presently 1.9 days.

AdvisorShares Psychedelics ETF Price Performance

NYSEARCA:PSIL remained flat at $23.23 on Friday. The company’s stock had a trading volume of 27,679 shares, compared to its average volume of 30,421. AdvisorShares Psychedelics ETF has a 12 month low of $14.37 and a 12 month high of $25.19. The company has a 50-day moving average of $20.68 and a 200 day moving average of $18.49.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in AdvisorShares Psychedelics ETF stock. CIBC Bancorp USA Inc. purchased a new stake in AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 25,019 shares of the company’s stock, valued at approximately $475,000. CIBC Bancorp USA Inc. owned 2.50% of AdvisorShares Psychedelics ETF as of its most recent filing with the SEC.

About AdvisorShares Psychedelics ETF

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.